NasdaqGS exchange. Sector: Healthcare. Industry: Diagnostics & Research. Location United States, Cincinnati.

Medpace Holdings, Inc. [MEDPUnited States

160.33USD3.16 (+1.97%)

• At close Fri Oct 07 2022

7,448,039,936 USD
MARKET CAP
49.074
PE
1.347
BETA (5y)
4.223
EPS

profit

360%

for 5 years

profit

149%

for 3 years

profit

87%

for 2 years

profit

21%

for 1 year

profit

-10%

for this year

About Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Medpace is a clinical research organization (CRO) conducting global clinical research for the development of drugs and medical devices. Read on.

Medpace Holdings, Inc.
https://www.medpace.com
© 2022 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.